SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-014578
Filing Date
2022-04-18
Accepted
2022-04-18 09:24:20
Documents
11
Period of Report
2022-05-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A_EGM alks-def14a_20220513.htm DEF 14A 397382
2 GRAPHIC gsn5isnsqxrs000003.jpg GRAPHIC 4902
3 GRAPHIC gsn5isnsqxrs000004.jpg GRAPHIC 1170
4 GRAPHIC gsn5isnsqxrs000001.jpg GRAPHIC 4902
5 GRAPHIC gsn5isnsqxrs000002.jpg GRAPHIC 14783
6 GRAPHIC gsn5isnsqxrs000008.jpg GRAPHIC 110090
7 GRAPHIC gsn5isnsqxrs000005.jpg GRAPHIC 1121
8 GRAPHIC gsn5isnsqxrs000009.jpg GRAPHIC 80477
9 GRAPHIC gsn5isnsqxrs000007.jpg GRAPHIC 1084
10 GRAPHIC gsn5isnsqxrs000006.jpg GRAPHIC 1146
11 COURTESY PDF COPY alks-def14a_20220513.pdf DEF 14A 202398
  Complete submission text file 0001564590-22-014578.txt   981456
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35299 | Film No.: 22831160
SIC: 2834 Pharmaceutical Preparations